Anika Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Anika Therapeutics, Inc. (ANIK) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $1.09 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2016-11-01
- Anika Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2016-09-30 was $645.00K, a 347.92% increase year-over-year.
- Anika Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2016-06-30 was $1.75M, a 1478.38% increase year-over-year.
- Anika Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2016-03-31 was -$1.31M.
- Anika Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2015-09-30 was $144.00K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month |
|---|---|---|---|
| 2016-09-30 | $645.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $2.40M derived: sum of 2 quarters · filed 2016-11-01 | $1.09M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $446.00K 10-Q · filed 2016-08-01 | |
| 2016-03-31 | -$1.31M 10-Q · filed 2016-05-03 | ||
| 2015-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $255.00K derived: sum of 2 quarters · filed 2016-11-01 | -$120.00K 10-Q · filed 2016-11-01 |
| 2015-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | -$264.00K 10-Q · filed 2016-08-01 | |
| 2015-03-31 | -$375.00K 10-Q · filed 2016-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |